Trial Information
The Influence of Soy Isoflavnoids on the Hypocholesterolemic Effects of Soy
Inclusion Criteria:
- men and post-menopausal women
- LDL-C > 4.1mmol/L at recruitment
- living within a 40 km radius of St. Michael's Hospital
Exclusion Criteria:
- lipid lowering medications
- clinical or biochemical evidence of diabetes, renal or hepatic disease
- body mass index (BMI) >38 kg/m2
- antibiotic use within the last three months
- hormone replacement therapy
- smoking or significant alcohol use (>1 drink/d)
- triglyceride level > 4.0mmol/L
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind, Primary Purpose: Treatment
Principal Investigator
David JA Jenkins, MD, PhD, DSc
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Toronto and St. Michael's Hospital
Authority:
Canada: Ethics Review Committee
Study ID:
REB235U
NCT ID:
NCT00877825
Start Date:
Completion Date:
April 2000
Related Keywords:
- Hyperlipidemia
- Cardiovascular Diseases
- Diet Therapy
- Cardiovascular Diseases
- Hyperlipidemias